Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome.
[This corrects the article DOI: 10.1371/journal.pone.0302298.].
Saved in:
| Main Authors: | Keyvan Razazi, Enora Berti, Jerome Cecchini, Guillaume Carteaux, Anoosha Habibi, Pablo Bartolucci, Romain Arrestier, Ségolène Gendreau, Nicolas de Prost, Anne Hulin, Armand Mekontso Dessap |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319527 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Continuous Renal Replacement Therapy with Polyacrylonitrile-Derived Filter on Caspofungin Concentration: A Retrospective Study
by: Romain Arrestier, et al.
Published: (2025-07-01) -
Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (The ANTIBIO-STA study): a randomised, controlled, open-label trialResearch in context
by: Alexandre Sabaté-Elabbadi, et al.
Published: (2025-04-01) -
Evaluating the safety profile of defibrotide in sickle cell disease: an <i>in vitro</i> study
by: Laura Bencheikh, et al.
Published: (2025-05-01) -
Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease
by: Armand Mekontso Dessap, et al.
Published: (2025-05-01) -
CHA2DS2-VASc scores to predict left atrial/left atrial appendage abnormalities in patients with sepsis-induced atrial fibrillation: A preliminary investigation
by: Vincent Labbé, et al.
Published: (2025-07-01)